Featured,Spotlight Stock,Trends & Articles UK Study Rules Magic Mushroom Compound Effective as Any Antidepressant Drugs By Dennis Mutua April 16, 2021 A study done by scientists from the UK has concluded that compound form magic mushroom is at least as good as antidepressant drugs. The study found out that the compound from magic mushroom is equally effective as any antidepressa...
Spotlight Stock,Trends & Articles PsyBio Submits Application to get Listed on OTCQX Market By Dennis Mutua April 15, 2021 Biotechnology company developing new class of drugs with psychoactive compounds PsyBio Therapeutics Corp (CVE: PSYB) has submitted its application to get its subordinate voting shares listed for trading on the OTCQX market. OTC...
Featured,Spotlight Stock,Trends & Articles Mydecine Announces Breakthrough in Research of Chemical Compounds and Therapeutic Effects of Natural Psilocybin By Dennis Mutua April 14, 2021 Biotech and life sciences company specializing in developing innovative solutions for mental illnesses Mydecine Innovations Group (NEO: MYCO) (OTC: MYCOF) announced having reached a key milestone in its ongoing research geared tow...
Psychedelic Stocks,Trends & Articles Mind Cure Health Files for Provisional Patent for Propriety Digital Therapeutics By Dennis Mutua April 13, 2021 Mental health and wellness company focused on investigation of psychoactive, psychedelic, and nootropic compounds, Mind Cure Health Inc. (CSE: MCUR) (OTCQB: MCURF) has filed for provisional patent with the United States Patent and...
Featured,Spotlight Stock,Trends & Articles Creso Pharma Acquiring Halucenex Life Sciences to Explore Genome Sequencing of Magic Mushroom By Dennis Mutua April 12, 2021 Pharmaceutical company developing cannabis extracted therapeutic, nutraceutical, and lifestyle products for human health Creso Pharma Ltd. (ASX: CPH) announced having entered an agreement to acquire psychedelics focused pharmaceut...
Psychedelic Stocks,Trends & Articles Dr. Thomas Laughren Joins BetterLife Pharma in the Capacity of a Regulatory Advisor By Dennis Mutua April 09, 2021 Former psychiatry division director in the Food and Drug Administration (FDA) Dr. Thomas Laughren has joined pharmaceutical company developing second generation psychedelics for neuro-psychiatric disorders BetterLife Pharma Inc. (...
Psychedelic Stocks,Trends & Articles Aikido Granted Sublicense for Psilocybin Treatment of Neuro-Inflamed Tissue in Cancer Patients By Dennis Mutua April 08, 2021 United States based pharmaceutical development company Aikido Pharma Inc. (AIKI) has received a sublicense for using psilocybin treatment of neuro-inflated tissue in patients suffering from cancer. This sublicense is related to...
Featured,Trends & Articles California Inches Closer Towards Decriminalizing the Use of Psychedelics By Dennis Mutua April 07, 2021 Efforts to decriminalize use psychedelics substances in California have been revived once again after a major state senate committee voted in favor of a bill allowing adults across California to possess and use magic mushrooms and...